A newly ausculted heart murmur is a common encounter in general practice, but navigating what comes next isn’t always straightforward. In this episode of the Partner Podcast, Dr. Lance Visser, board-certified veterinary cardiologist, breaks down the essentials of myxomatous mitral valve disease, including staging and diagnostic criteria, the landmark EPIC trial data, and what the recent approval of VETMEDIN® (pimobendan) by the FDA for the preclinical B2 dogs means for clinical practice.
Sponsored by Boehringer Ingelheim
This podcast is RACE-approved for 1 hour of CE credit through August 5, 2028. Earn your CE credit here.
Podden och tillhörande omslagsbild på den här sidan tillhör
Clinician's Brief. Innehållet i podden är skapat av Clinician's Brief och inte av,
eller tillsammans med, Poddtoppen.
